Analyze Diet
Frontiers in veterinary science2024; 11; 1285000; doi: 10.3389/fvets.2024.1285000

The impact of the administration of red ginseng (Panax ginseng) on lipid metabolism and free fatty acid profiles in healthy horses using a molecular networking approach.

Abstract: This study investigated the potential benefits of the administration of red ginseng (RG) on lipid metabolism and the profiles of individual free fatty acids (FFAs) in healthy horses. Eight healthy horses, raised under similar conditions, were randomly divided into two groups, each comprising four horses. The experimental group received powdered RG (600 mg/kg/day) mixed with a carrier, and the control group received only the carrier. The parameters associated with lipid metabolism and probable adverse effects were evaluated in both groups after 3 weeks. The computational molecular networking (MN) approach was applied to analyze the FFA profiles. The results indicated that RG administration significantly reduced blood triglyceride levels in the experimental group. Analysis of the FFAs using MN revealed significant decreases in specific types of FFAs (C12:0, dodecanoic acid; C14:0, myristric acid; C18:1, oleic acid; C18:2, linoleic acid). RG consumption did not produce significant adverse effects on the renal, hepatic, and immune functions. Thus, RG was found to effectively modulate lipid metabolism and the levels of individual FFAs. The application of the MN for the analysis of FFAs represents a novel approach and can be considered for future research.
Publication Date: 2024-01-24 PubMed ID: 38332753PubMed Central: PMC10851614DOI: 10.3389/fvets.2024.1285000Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article examines the effects of red ginseng (a type of herb) on lipid metabolism and free fatty acid profiles in healthy horses. The study found that administering red ginseng can positively alter lipid metabolism and decrease specific types of free fatty acids, with no adverse kidney, liver, or immune system effects.

Introduction and Methodology

  • The research was undertaken to study the effect of red ginseng (RG) on horses’ lipid metabolism and levels of individual free fatty acids (FFAs). Lipids play a crucial role in various physiological processes, and their disbalance can lead to various health complications.
  • The study commenced with eight horses divided equally into two groups – the experimental group and the control group. The horses were raised under uniform conditions to ensure accurate results.
  • The experimental group was given a diet containing powdered RG mixed with a carrier at a dose rate of 600 mg/kg/day. The control group, on the other hand, was only given the carrier.

Measurements and Analysis

  • After three weeks, the horses’ lipid metabolism parameters were tested. Simultaneously, checks were made for potential adverse effects.
  • Furthermore, free fatty acid profiles were analyzed using computational molecular networking. This advanced technology provided a deeper level of understanding of the changes in FFAs.

Results and Conclusion

  • The results showed that the RG administration significantly reduced blood triglyceride levels, pointing to a positive impact on lipid metabolism.
  • The molecular network analysis revealed a notable decrease in certain FFAs, namely dodecanoic acid, myristic acid, oleic acid, and linoleic acid.
  • The study also indicated that consuming RG did not lead to adverse effects on the horses’ renal, hepatic, and immune functions, colloquially known as kidney, liver, and immune system functions.
  • The authors concluded that RG can effectively regulate lipid metabolism and individual FFA levels, confirming its benefits in maintaining health.
  • The use of molecular networking in the analysis of FFA profiles was also justified and encouraged for future research.

Cite This Article

APA
Kwak YB, Yoo HH, Yoon J. (2024). The impact of the administration of red ginseng (Panax ginseng) on lipid metabolism and free fatty acid profiles in healthy horses using a molecular networking approach. Front Vet Sci, 11, 1285000. https://doi.org/10.3389/fvets.2024.1285000

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 11
Pages: 1285000
PII: 1285000

Researcher Affiliations

Kwak, Young Beom
  • Racing Laboratory, Korea Racing Authority, Jeju, Republic of Korea.
Yoo, Hye Hyun
  • Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.
Yoon, Jungho
  • Equine Referral Clinic, Jeju Stud Farm, Korea Racing Authority, Jeju, Republic of Korea.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 61 references
  1. Choi S-H, Jung S-W, Lee B-H, Kim H-J, Hwang S-H, Kim H-K. Ginseng pharmacology: A new paradigm based on Gintonin-lysophosphatidic acid receptor interactions. Front Pharmacol (2015) 6:245.
    doi: 10.3389/fphar.2015.00245pmc: PMC4621423pubmed: 26578955google scholar: lookup
  2. Lee KJ, Ji GE. The effect of fermented red ginseng on depression is mediated by lipids. Nutr Neurosci (2014) 17:7–15.
  3. Attele AS, Wu JA, Yuan C-S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol (1999) 58:1685–93.
    doi: 10.1016/S0006-2952(99)00212-9pubmed: 10571242google scholar: lookup
  4. Kiefer D, Pantuso T. Panax Ginseng. Am Fam Physician (2003) 68:1539–42.
    pubmed: 14596440
  5. Kim S-H, Park K-S. Effects of Panax Ginseng extract on lipid metabolism in humans. Pharmacol Res (2003) 48:511–3.
    doi: 10.1016/S1043-6618(03)00189-0pubmed: 12967598google scholar: lookup
  6. Park TY, Hong M, Sung H, Kim S, Suk KT. Effect of Korean red ginseng in chronic liver disease. J Ginseng Res (2017) 41:450–5.
    doi: 10.1016/j.jgr.2016.11.004pmc: PMC5628344pubmed: 29021690google scholar: lookup
  7. Keum Y-S, Park K-K, Lee J-M, Chun K-S, Park JH, Lee SK. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett (2000) 150:41–8.
    doi: 10.1016/S0304-3835(99)00369-9pubmed: 10755385google scholar: lookup
  8. Lee S, Rhee D-K. Effects of ginseng on stress-related depression, anxiety, and the hypothalamic–pituitary–adrenal Axis. J Ginseng Res (2017) 41:589–94.
    doi: 10.1016/j.jgr.2017.01.010pmc: PMC5628357pubmed: 29021708google scholar: lookup
  9. Elghandour MM, Reddy PRK, Salem AZ, Reddy PPR, Hyder I, Barbabosa-Pliego A. Plant bioactives and extracts as feed additives in horse nutrition. J Equine Vet (2018) 69:66–77.
  10. Pearson W, Omar S, Clarke AF. Low-dose ginseng (Panax Quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus 1 in horses. Can J Vet Res (2007) 71:213–7.
    pmc: PMC1899868pubmed: 17695597
  11. Chung E, Kwok W, Leung D, Leung G, Tang F, Wan T. Detection and confirmation of Ginsenosides in horse urine by Gc–Ms and Lc–Ms. Chromatographia (2009) 69:923–32.
    doi: 10.1365/s10337-009-1034-ygoogle scholar: lookup
  12. Wang TY, Liu M, Portincasa P, Wang DQH. New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Investig (2013) 43:1203–23.
    doi: 10.1111/eci.12161pmc: PMC3996833pubmed: 24102389google scholar: lookup
  13. Stich V, Berlan M. Physiological regulation of Nefa availability: lipolysis pathway. Proc Nutr Soc (2004) 63:369–74.
    doi: 10.1079/PNS2004350pubmed: 15294057google scholar: lookup
  14. Pilz S, März W. Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med (2008) 46:429–34.
    doi: 10.1515/CCLM.2008.118pubmed: 18605928google scholar: lookup
  15. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet (2014) 384:626–35.
    doi: 10.1016/S0140-6736(14)61177-6pubmed: 25131982google scholar: lookup
  16. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab (2004) 89:463–78.
    doi: 10.1210/jc.2003-030723pubmed: 14764748google scholar: lookup
  17. Utzschneider KM, Kahn SE. The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2006) 91:4753–61.
    doi: 10.1210/jc.2006-0587pubmed: 16968800google scholar: lookup
  18. Sarafidis P, Bakris G. Non-esterified fatty acids and blood pressure elevation: A mechanism for hypertension in subjects with obesity/insulin resistance?. J Hum Hypertens (2007) 21:12–9.
    doi: 10.1038/sj.jhh.1002103pubmed: 17051236google scholar: lookup
  19. Oram JF, Bornfeldt KE. Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes. Front Biosci (2004) 9:1240–53.
    doi: 10.2741/1300pubmed: 14977541google scholar: lookup
  20. Opie LH. The metabolic vicious cycle in heart failure. Lancet (2004) 364:1733–4.
    doi: 10.1016/S0140-6736(04)17412-6pubmed: 15541431google scholar: lookup
  21. Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart-type fatty acid–binding protein: diagnostic assays and clinical applications. Clin Chem (2006) 52:19–29.
    doi: 10.1373/clinchem.2005.056143pubmed: 16269514google scholar: lookup
  22. Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in health and disease. Physiol Rev (2019) 100:171–210.
    doi: 10.1152/physrev.00041.2018pubmed: 31487233google scholar: lookup
  23. Sobczak AIS, Blindauer CA, Stewart AJ. Changes in plasma free fatty acids associated with Type-2 diabetes. Nutrients (2019) 11.
    doi: 10.3390/nᄉ2022pmc: PMC6770316pubmed: 31466350google scholar: lookup
  24. Kwak YB, Seo JI, Yoo HH. Exploring metabolic pathways of Anamorelin, a selective agonist of the growth hormone Secretagogue receptor, via molecular networking. Pharmaceutics (2023) 15:2700.
  25. Aksenov AA, Laponogov I, Zhang Z, Doran SLF, Belluomo I, Veselkov D. Auto-deconvolution and molecular networking of gas chromatography-mass spectrometry data. Nat Biotechnol (2021) 39:169–73.
    doi: 10.1038/s41587-020-0700-3pmc: PMC7971188pubmed: 33169034google scholar: lookup
  26. Kwak YB, Lee E, Choi H, Park T, Kim A, Kim J. A pharmacokinetic study on red ginseng with furosemide in equine. Front Vet Sci (2023) 10:1319998.
    doi: 10.3389/fvets.2023.1319998pmc: PMC10704239pubmed: 38076549google scholar: lookup
  27. Kwak YB, Rehman SU, Yoo HH. Quantification of three prohibited anabolic-androgenic steroids in equine urine using gas chromatography-tandem mass spectrometry. Mass Spectrom Lett (2023) 14:104–9.
    doi: 10.5478/MSL.2023.14.3.104google scholar: lookup
  28. Kwak YB, Yu J, Yoo HH. A quantitative method for the simultaneous detection of Sr9009 and Sr9011 in equine plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry. Drug Test Anal (2022) 14:1532–8.
    doi: 10.1002/dta.3271pubmed: 35396832google scholar: lookup
  29. Kwak YB, Yu J, Im EJ, Jeong BS, Yoo HH. Study of cobalt doping control via various routes in thoroughbred horses. Drug Test Anal (2022) 14:718–23.
    doi: 10.1002/dta.3192pubmed: 34750992google scholar: lookup
  30. Kwak YB, Choi MS. Identification of a metabolite for the detection of the hydrophilic drug Diisopropylamine for doping control. J Pharm Biomed Anal (2023) 234:115576.
    doi: 10.1016/j.jpba.2023.115576pubmed: 37459832google scholar: lookup
  31. Kwak YB, Yu J, Yoo HH. Simultaneous liquid chromatography tandem mass spectrometric determination of 35 prohibited substances in equine plasma for doping control. Mass Spectrom Lett (2022) 13:158–65.
    doi: 10.5478/MSL.2022.13.4.158google scholar: lookup
  32. Yoon SJ, Kim SK, Lee NY, Choi YR, Kim HS, Gupta H. Effect of Korean red ginseng on metabolic syndrome. J Ginseng Res (2021) 45:380–9.
    doi: 10.1016/j.jgr.2020.11.002pmc: PMC8134847pubmed: 34025131google scholar: lookup
  33. Lee SM, Bae BS, Park HW, Ahn NG, Cho BG, Cho YL. Characterization of Korean red ginseng (Panax Ginseng Meyer): history, preparation method, and chemical composition. J Ginseng Res (2015) 39:384–91.
    doi: 10.1016/j.jgr.2015.04.009pmc: PMC4593794pubmed: 26869832google scholar: lookup
  34. Jo SK, Kim IS, Yoon KS, Yoon HH, Yoo HH. Preparation of Ginsenosides Rg3, Rk1, and Rg5-selectively enriched ginsengs by a simple steaming process. Eur Food Res Technol (2015) 240:251–6.
    doi: 10.1007/s00217-014-2370-1google scholar: lookup
  35. Kim SY, Seo SK, Choi YM, Jeon YE, Lim KJ, Cho S. Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women: A double-blind randomized controlled trial. Menopause (2012) 19:461–6.
    doi: 10.1097/gme.0b013e3182325e4bpubmed: 22027944google scholar: lookup
  36. Wu W, Song F, Guo D, Mi J, Qin Q, Yu Q. Mass spectrometry-based approach in ginseng research: A promising way to metabolomics. Curr Anal Chem (2012) 8:43–66.
  37. Zhang Y, Yu L, Cai W, Fan S, Feng L, Ji G. Protopanaxatriol, a novel Pparγ antagonist from Panax Ginseng, alleviates steatosis in mice. Sci Rep (2014) 4:7375.
    doi: 10.1038/srep07375pmc: PMC4260220pubmed: 25487878google scholar: lookup
  38. Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, Wang J. Ginsenoside Rb1 reduces fatty liver by activating amp-activated protein kinase in obese rats. J Lipid Res (2013) 54:1430–8.
    doi: 10.1194/jlr.M035907pmc: PMC3622335pubmed: 23434611google scholar: lookup
  39. Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and Banaba on glucose homeostasis in relation to Ppar-alpha, Ppar-gamma, and Lpl Mrna expressions. Life Sci (2005) 77:3344–54.
    doi: 10.1016/j.lfs.2005.05.043pubmed: 15979095google scholar: lookup
  40. Liu W, Zheng Y, Han L, Wang H, Saito M, Ling M. Saponins (Ginsenosides) from stems and leaves of Panax Quinquefolium prevented high-fat diet-induced obesity in mice. Phytomedicine (2008) 15:1140–5.
    doi: 10.1016/j.phymed.2008.07.002pubmed: 18768305google scholar: lookup
  41. Lee H, Choi J, Shin SS, Yoon M. Effects of Korean red ginseng (Panax Ginseng) on obesity and adipose inflammation in Ovariectomized mice. J Ethnopharmacol (2016) 178:229–37.
    doi: 10.1016/j.jep.2015.12.017pubmed: 26707750google scholar: lookup
  42. Kim SJ, Yuan HD, Chung SH. Ginsenoside Rg1 suppresses hepatic glucose production via amp-activated protein kinase in Hepg2 cells. Biol Pharm Bull (2010) 33:325–8.
    doi: 10.1248/bpb.33.325pubmed: 20118562google scholar: lookup
  43. Quan H-Y, Yuan H-D, Kim DY, Zhang Y, Chung SH. Korean red ginseng attenuates hepatic lipid accumulation via Ampk activation in human hepatoma cells. Food Sci Biotechnol (2010) 19:207–12.
    doi: 10.1007/s10068-010-0028-8google scholar: lookup
  44. Lee S, Lee MS, Kim CT, Kim IH, Kim Y. Ginsenoside Rg3 reduces lipid accumulation with amp-activated protein kinase (Ampk) activation in Hepg2 cells. Int J Mol Sci (2012) 13:5729–39.
    doi: 10.3390/ijms13055729pmc: PMC3382760pubmed: 22754327google scholar: lookup
  45. Chang W-L, Ho Y-H, Huang Y-C, Huang S-F, Lin J-Y, Lin H-C. The inhibitory effect of Ginsenoside Rg1 on glucose and lipid production in human Hepg2 cells. Adaptive Med (2013) 5:181–8.
    doi: 10.4247/AM.2013.ABD068google scholar: lookup
  46. Lee MS, Shin Y, Kim Y. Effect of the high hydrostatic pressure extract of Korean ginseng on hepatic lipid metabolism and amp-activated protein kinase activation in Hepg2 cells (1045.25). FASEB J (2014) 28:1045.25.
  47. Sekiya K, Okuda H, Hotta Y, Arichi S. Enhancement of adipose differentiation of mouse 3t3-L1 fibroblasts by Ginsenosides. Phytother Res (1987) 1:58–60.
    doi: 10.1002/ptr.2650010203google scholar: lookup
  48. Jung S, Lee M-S, Shin Y, Kim C-T, Kim I-H, Kim YS. Anti-obesity and anti-inflammatory effects of high hydrostatic pressure extracts of ginseng in high-fat diet induced obese rats. J Funct Foods (2014) 10:169–77.
    doi: 10.1016/j.jff.2014.06.007google scholar: lookup
  49. Lianqun J, Xing J, Yixin M, Si C, Xiaoming L, Nan S. Comprehensive multiomics analysis of the effect of Ginsenoside Rb1 on hyperlipidemia. Aging (Albany NY) (2021) 13:9732–47.
    doi: 10.18632/aging.202728pmc: PMC8064217pubmed: 33744860google scholar: lookup
  50. Song YB, An YR, Kim SJ, Park HW, Jung JW, Kyung JS. Lipid metabolic effect of Korean red ginseng extract in mice fed on a high-fat diet. J Sci Food Agric (2012) 92:388–96.
    doi: 10.1002/jsfa.4589pubmed: 21918993google scholar: lookup
  51. Kim H-J, Cho C-W, Hwang J-T, Son N, Choi JH, Shim G-S. Lc-Ms-based Metabolomic analysis of serum and livers from red ginseng-fed rats. J Ginseng Res (2013) 37:371–8.
    doi: 10.5142/jgr.2013.37.371pmc: PMC3818965pubmed: 24198664google scholar: lookup
  52. Köberlin MS, Snijder B, Heinz LX, Baumann CL, Fauster A, Vladimer GI. A conserved circular network of Coregulated lipids modulates innate immune responses. Cell (2015) 162:170–83.
    doi: 10.1016/j.cell.2015.05.051pmc: PMC4523684pubmed: 26095250google scholar: lookup
  53. Rodriguez-Cuenca S, Pellegrinelli V, Campbell M, Oresic M, Vidal-Puig A. Sphingolipids and Glycerophospholipids – the “Ying and Yang” of lipotoxicity in metabolic diseases. Prog Lipid Res (2017) 66:14–29.
    doi: 10.1016/j.plipres.2017.01.002pubmed: 28104532google scholar: lookup
  54. Vonkova I, Saliba A-E, Deghou S, Anand K, Ceschia S, Doerks T. Lipid cooperativity as a general membrane-recruitment principle for Ph domains. Cell Rep (2015) 12:1519–30.
    doi: 10.1016/j.celrep.2015.07.054pubmed: 26299969google scholar: lookup
  55. Shergis JL, Zhang AL, Zhou W, Xue CC. Panax Ginseng in randomised controlled trials: A systematic review. Phytother Res (2013) 27:949–65.
    doi: 10.1002/ptr.4832pubmed: 22969004google scholar: lookup
  56. Hu Z, Yang X, Ho PCL, Chan SY, Heng PWS, Chan E. Herb-drug interactions: A literature review. Drugs (2005) 65:1239–82.
  57. Ubhayasekera SJ, Staaf J, Forslund A, Bergsten P, Bergquist J. Free fatty acid determination in plasma by Gc-Ms after conversion to Weinreb amides. Anal Bioanal Chem (2013) 405:1929–35.
    doi: 10.1007/s00216-012-6658-3pubmed: 23307129google scholar: lookup
  58. Singer P, Wirth M, Berger I. A possible contribution of decrease in free fatty acids to low serum triglyceride levels after diets supplemented with N− 6 and N− 3 polyunsaturated fatty acids. Atherosclerosis (1990) 83:167–75.
    doi: 10.1016/0021-9150(90)90162-Cpubmed: 2146966google scholar: lookup
  59. Kusunoki J, Kanatani A, Moller DE. Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome. Endocrine (2006) 29:91–100.
    doi: 10.1385/ENDO:29:1:91pubmed: 16622296google scholar: lookup
  60. Yan B, Liu Y, Shi A, Wang Z, Aa J, Huang X. Investigation of the Antifatigue effects of Korean ginseng on professional athletes by gas chromatography-time-of-flight-mass spectrometry-based metabolomics. J AOAC Int (2018) 101:701–7.
    doi: 10.5740/jaoacint.17-0220pubmed: 28927488google scholar: lookup
  61. Hwang H, Kim J, Park J, Yun H, Cheon W-K, Kim B. Red ginseng treatment for two weeks promotes fat metabolism during exercise in mice. Nutrients (2014) 6:1874–85.
    doi: 10.3390/n恑874pmc: PMC4042568pubmed: 24803098google scholar: lookup

Citations

This article has been cited 0 times.